Stocks and Investing
Stocks and Investing
Fri, October 14, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Do Kim Maintained (TVTX) at Buy with Decreased Target to $38 on, Oct 14th, 2022
Do Kim of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Decreased Target from $39 to $38 on, Oct 14th, 2022.
Do has made no other calls on TVTX in the last 4 months.
There are 3 other peers that have a rating on TVTX. Out of the 3 peers that are also analyzing TVTX, 0 agree with Do's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Do
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $42 on, Monday, August 8th, 2022
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $45 on, Friday, August 5th, 2022
- Edward Nash of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $42 on, Thursday, July 14th, 2022
Contributing Sources